Akoya Biosciences, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
Akoya Biosciences announces its Q1 2025 financial results, showing a net loss but also highlighting its ongoing merger agreement with Quanterix.
Akoya Biosciences' Q3 2024 results show a decrease in revenue and a net loss, alongside restructuring and cost-saving initiatives.
10-Q: Akoya Biosciences Reports Second Quarter 2024 Results: Revenue Declines Amid Cost-Cutting Measures
Akoya Biosciences experienced a decrease in revenue and a net loss for the second quarter of 2024, while implementing cost-saving initiatives including a workforce reduction and facility consolidation.
Akoya Biosciences' first quarter 2024 results show a decrease in revenue and a net loss, impacted by lower instrument sales and restructuring costs.